AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06297473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone-/video follow-up
Description: The yearly routine review of patients takes place by using a telephone or video interview rather than in-person interview in the endocrine outpatient department.~All other assessments, e.g. biochemical, MRI, is conducted as usual.
Study NCT06297473 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: In-person follow-up
Description: The yearly routine review on patients takes place at the endocrine outpatient department
Study NCT06212830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: Gabapentin 200 mg twice a day, starting from the night prior to the procedure and continue 48 hours after
Study NCT06212830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Targin
Description: Targin 5 mg twice a day after the procedure for 48 hours
Study NCT06212830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NSAID
Description: Nurofen (NSAID) 200 mg twice a day after the procedure for 48 hours
Study NCT06212830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: Paracetamol 500 mg every 4 hours during waking hours after the procedure for 48 hours
Study NCT06147583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation of an insulin pump failure
Description: The intervention will consist in simulating an insulin pump failure by suspending insulin infusion and monitoring the consequent hyperglycemia.
Study NCT04457492 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application of FES to the Face
Description: Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated.
Study NCT05412953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT05412953 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tonation Breathing Technique
Description: Participate in tonation breathing techniques
Study NCT05253092 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual mindfulness meditation
Description: Subjects will participate in 30 minutes of a virtual mindfulness meditation session, totaling eight sessions.
Study NCT05640141 — intervention group
Intervention type: PROCEDURE
Intervention: MRI evaluation
Description: Multimodal MRI evaluation :~* T1 structural,~* Resting echo planar imaging~* Diffusion-weighted imaging~* Arterial sping labeling~* Fluid-attenuated inversion recovery
Study NCT05640141 — intervention group
Intervention type: BEHAVIORAL
Intervention: Actimetry & IMU
Description: Evaluation of daily activities and life rythms (physical activity, inactivity, sleep) using actimeters (Motion 8), inertial sensors (GaitUP) and questionaires during 14 days :~* Actimetry : evaluation of daily activity and inactivity, sleep rythms~* Inertial sensors : gait evaluation during daily activities~* Questionaires : sleep (Spiegel \& St Mary's Hospitral) and fatigue (MFI-20)
Study NCT05640141 — intervention group
Intervention type: BEHAVIORAL
Intervention: Gait evaluation
Description: Evaluation of gait characteristics (spatio-temporal parameters \& non-linear characteristics) in virtual environment :~* Locomotor simple task : gait only in congruent environment~* Locomotor dual task : gait in similar environment combined with a visually displayed Stroop task~* Sensorimotor gait adaptaition : evaluation of the adaptation capability throughout a split-belt treadmill sequence (realized in simple or dual -combined with the visual Stroop task-)
Study NCT05640141 — intervention group
Intervention type: BEHAVIORAL
Intervention: Neuropsychological evaluation
Description: Complete neuropsychological examination including attentional and executive functions, learning and retrieval abilities in episodic memory and general cognitive skills :~* Divided attention (TAP; test of attentional performance)~* California Verbal Learning Test~* The Rey-Osterrieth Complex Figure~* Symbol search and coding (WAIS-IV)~* Go/No-go (TAP)~* Flexibility (TAP)~* Original task of multimodal integration~* Verbal fluencies (GREFEX)
Study NCT06757894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zuberitamab
Description: 375 mg/m², administered on Day 1 (D1) of Cycles 1-6 (C1-C6)
Study NCT06757894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: 90 mg/m², administered on D1-2 of C1-C6
Study NCT06756594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine-Propofol
Description: efficacy of sedation with Dexmedetomidine-Propofol combination in the upper or lower gastrointestinal system endoscopy.
Study NCT06756594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine-Propofol
Description: efficacy of sedation with Ketamine-Propofol combination in the upper or lower gastrointestinal system endoscopy.
Study NCT06194227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-speed, Cognitive Challenge Yoga
Description: Participants in this group will receive in-person high-speed yoga with cuing 3 times per week for 24 consecutive weeks for a total of 72 training sessions of 1 hour duration. Subjects will move as quickly as possible from one pose to another.
Study NCT06194227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Yoga
Description: Participants will perform in-person controlled speed Hatha yoga 3 times per week for 24 weeks for a total of 72 sessions of 1 hour duration.
Study NCT05677906 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking only (Step It Up!)
Description: Participants will meet weekly for 60 minutes and walk together as a group. Participants will progressively build up to walking for 45 minutes at a brisk pace. Walks will start with a check-in and end with stretching as a group.
Study NCT05677906 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking only (Step It Up!)
Description: Participants will meet weekly for 60 minutes and walk together as a group. Participants will progressively build up to walking for 45 minutes at a brisk pace. Walks will start with a check-in and end with stretching as a group.
Study NCT05677906 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined (Step It Up! plus Civic Engagement)
Description: Participants in the combined groups will meet weekly for 90 minutes with group members. They will participate in a group walk for 60 minutes followed by 30 minutes of civic engagement aimed at improving walkability in the community
Study NCT05581381 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: empathy training program
Description: Empathy training, a total of 8 weeks of training (1 time a week, 1 hour each time)
Study NCT04927949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cangrelor perfusion during PCI
Description: Cangrelor perfusion (started before PCI) with intravenous bolus of 30 microgram/kg, followed by a perfusion of 4 microgram/kg/min during 2 hours or until the end of the PCI if longer
Study NCT05232903 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SVF therapy group
Description: The active treatment is an intravenous injection with the stromal vascular fraction (SVF) harvested from the patient's own fatty tissue.
Study NCT04810806 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography within 2 hours after randomization
Description: After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Immediate CAG group will receive CAG within 2 hours after randomization. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
Study NCT04810806 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Delayed coronary angiography after stabilization of heart failure
Description: After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Delayed CAG group will receive CAG after stabilization of ADHF; improvement of symptoms and signs of heart failure. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
Study NCT04927949 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: standard PCI
Description: primary PCI without cangrelor
Study NCT04927949 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: standard PCI
Description: primary PCI without cangrelor
Study NCT05052151 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low dialysate temperature
Description: 35°C
Study NCT05052151 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High dialysate temperature
Description: 37°C
Study NCT05052151 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low dialysate bicarbonate concentration
Description: 30 mmol/L
Study NCT05052151 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High dialysate bicarbonate concentration
Description: 38 mmol/L
Study NCT04712279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin 0.6mg/kg/day
Description: Use of ivermectin 0.6m/kg/day q.d.for 05 days
Study NCT04712279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin 1.0mg/kg/day
Description: Ivermectin 1.0mg/kg/day q.d. for 05 days
Study NCT04712279 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo q.d.for 05 days
Study NCT06341309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Liposome
Description: 70 mg/m\^2 , d1, 14 days per cycle. Until the disease progresses, intolerable toxicity occurs, and the patient withdraws informed consent (whichever comes first).
Study NCT06341309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 5mg/kg, d1, 14 days per cycle. Until the disease progresses, intolerable toxicity occurs, and the patient withdraws informed consent (whichever comes first).
Study NCT04712279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxychloroquine
Description: Hydroxychloroquine 200mg/day q.d. for 05 days
Study NCT04712279 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydroxychloroquine
Description: Hydroxychloroquine 200mg/day q.d. for 05 days
Study NCT04849429 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) with exosomes
Description: Autologous Platelet rich plasma (PRP) with exosomes Following skin disinfection of the back 2 ml from the total PRPex procured will be injected as soon as possible by an fluoroscopy guided lateral approach.
Study NCT04672850 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: The participants will consume 2 capsules daily for three months
Study NCT04672850 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The participants will consume 2 capsules daily for three months
Study NCT04519853 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Glycemic Load Diet
Description: Food delivery service will provide a low glycemic load diet for 8 weeks
Study NCT04849429 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: placebo : 2 ml normal saline para discal administration
Study NCT04899167 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI 1.5T and 3.0T
Description: Magnetic Resonance Imaging for Renal Fibrosis
Study NCT04576897 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Velacur
Description: Ultrasound elasticity imaging
Study NCT04708509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extubation Advisor
Description: Participants undergoing a Spontaneous Breathing Trial (SBT) to assess readiness for extubation will be connected to a portable monitor displaying ECG, capnography, and other waveforms. This monitor will also be connected to a laptop containing the Extubation Advisor (EA) software. During the SBT, relevant patient information will be entered into the EA application and the EA application will record waveform data. When the SBT is complete, the EA application will analyze the waveform and patient data to generate a score summarizing the risk of extubation failure. A report will be generated and provided to the respiratory therapist and attending physician to help determine whether to proceed with extubation or not. Patients will be followed for 72 hours after extubation, when the clinical outcome case report form will be completed.
Study NCT06416254 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fibre-enriched diet
Description: The fibre-enriched diet contains fibre-enriched foods in which a portion of digestible carbohydrates are replaced with isolated dietary fibres. The fibre-enriched study foods are consumed as part of a full meal plan provided to participants.
Study NCT06416254 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control diet
Description: The control diet contains non-fibre-enriched study foods. The control study foods are consumed as part of a full meal plan provided to participants.
Study NCT06431230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: standard high-intensity interval training
Description: The project will use an intensive intermittent exercise intervention according to the high-intensity interval training programme. The programme will be implemented during physical education lessons. It involves 4 minutes of exercise in a structure of 20 seconds of intense effort and 10 seconds of rest, for a total of 8 cycles. It will be repeated twice a week (in two PE lessons) for 8 weeks. It is based on the standard physical exercises: squats, push-ups, sit-ups, toe-touches, mountain climber, jumping jacks, standing abs twist and squat to side.
Study NCT06431230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: plyometric high-intensity interval training
Description: The project will use an intensive intermittent exercise intervention according to the high-intensity interval training programme. The programme will be implemented during physical education lessons. It involves 4 minutes of exercise in a structure of 20 seconds of intense effort and 10 seconds of rest, for a total of 8 cycles. It will be repeated twice a week (in two PE lessons) for 8 weeks. However, there is a difference, comparing to the St-HIIT, related to different exercises used in protocol. This kind of HIIT programme will be based on plyometric exercises: jumping jacks, skip A, skip C, jumps back into a push-up position and returns to the squat position, throwing the legs out of support and jumping out, jumping out of a squat.
Study NCT05351242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thermotherapy/sauna bath
Description: Thermotherapy/sauna bath
Study NCT03885141 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Zolpidem
Description: Zolpidem or Placebo if there is a wake up during the night
Study NCT03885141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zolpidem
Description: Zolpidem or Placebo if there is a wake up during the night
Study NCT06112951 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extracorporeal Photopheresis
Description: Patients randomized into the interventional group will receive ECP. ECP will be started within one week after randomization. Initially a two-day treatment cycle will be performed once every second week for the first two months. Then, a two-day treatment cycle will be performed once a month for 6 months.
Study NCT05365633 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Empowerment activity-enhanced tobacco cessation assistance
Description: Participants will receive standard Tobacco Treatment Research Program (TTRP) tobacco cessation assistance either remotely or in-person: 6 weekly counseling sessions and 12 weeks of combination NRT (nicotine patches + nicotine gum or lozenges). During the 6 weeks of counseling, participants will also engage in at least 4 'empowerment activities' (i.e., SGM social change mobilization and community-building activities48) for a total of at least 8 hours. Activities will be tailored to each participant's comfort level and provide COVID-19 risk-reduction options (e.g., remote or masked outdoor activities). Examples are: (i) running tobacco-free Pride events that occur in Jun and Oct in OK; (ii) organizing a virtual SGM town hall to inform the OK State Plan on Aging; (iii) SGM-relevant legislative phone banking (e.g., regarding transgender student participation in school athletics); and (iv) follow-up surveying of Freedom OK's name and gender marker change clinic72 participants.
Study NCT06024044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobilization Training
Description: The participants in the training group were given hysterectomy postoperative mobilization training by the researcher (B.K) using presentation and verbal information technique. A Post-Operative Follow-up Chart was given to the participants to fill in the 1st and 2nd postoperative days. The training group participants were followed up by the researcher on the 0th and 1st days after the operation in line with the mobilization training they received. The Post-Operative Follow-up Chart questioning the patients' mobilization times, distances, bowel functions and pain scores was filled in by the researcher in detail by face-to-face interview method. Mobilization time (minutes) and distance (meters) were evaluated by the patients and their relatives, and recorded on the chart, using the stopwatch and pedometer on the personal mobile phones of the patients.
Study NCT06383468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK120
Description: 300mg Q2W subcutaneous injection thereafter until week 50.
Study NCT06383468 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AK120
Description: 300mg Q2W subcutaneous injection thereafter until week 50.
Study NCT04906057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Forced Aerobic Exercise (FE)
Description: High-rate aerobic exercise on a semi-recumbent custom-designed stationary cycle ergometer
Study NCT04906057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Voluntary Aerobic Exercise (VE)
Description: Voluntary-rate aerobic exercise on a semi-recumbent stationary cycle ergometer
Study NCT04896567 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cell isolation
Description: Tissue from kidney biopsy will be used to isolate Cluster Differentiation 34+ cells.
Study NCT05792852 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENGAGE
Description: ENGAGE is a group intervention designed to improve social participation within the context of the COVID-19 pandemic.
Study NCT05273203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FIM-1
Description: A football group (12 participants/session) will participate in 60 minutes football training that will contain warm-up, football technical drills and exercises, fitness exercises and football game.
Study NCT05273203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FIM-2
Description: A football group (12 participants/session) will participate in 60 minutes football training that will contain warm-up, football technical drills and exercises, fitness exercises and football game.
Study NCT05273203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FIM-3
Description: A football group (12 participants/session) will participate in 60 minutes football training that will contain warm-up, football technical drills and exercises, fitness exercises and football game.
Study NCT05273203 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control
Description: No football training will be performed during 6 months period. Participation only in measurements at baseline and at 6 months.
Study NCT05032131 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADSVF
Description: Group 1 and 2 : Escalating dose of ADSVF injection (5 millions of cells, 10 millions of cells and 20 millions of cells).
Study NCT06376201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amphotericin B cholesterol-sulfate complex for injection
Description: Patients were eligible for enrollment on antifungal therapy with injectable amphotericin B cholesterol-sulfate complex (ABCD) at the same time as a treatment for underlying disease.~Dosage: According to the patient's condition and the investigator's judgment, the initial dose of ABCD can be 0.5-1.0mg/kg/d, and the dose can be increased daily according to the situation, and the therapeutic dose can be increased to 3.0-4.0mg/kg/d on the third day.~Course of treatment: ≥ 14 days (whether to continue to receive trial drug treatment after 14 days is decided by the investigator according to the patient's condition).
Study NCT05191615 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Job crafting training
Description: Consists of two main parts. In the first part, both managers and employees will be trained in the principles of SDT and JD-R. For managers, particular attention will be paid to the provision of need support and work values. For employees, particular attention will be paid to employees' opportunities for job crafting and promoting their basic psychological need satisfaction at work.~In the second part of the intervention, participants will have the opportunity to discuss their current health status and receive preventive health recommendations from a preventive care specialist.
Study NCT05046418 — intervention group
Intervention type: OTHER
Intervention: Hypoallergenic formula containing synbiotics
Description: An extensively hydrolysed formula containing synbiotics or an amino acid formula containing synbiotics.